ストックスクリーナーアプリを入手
4.05
0.75%
0.03
前日終値:
$4.02
開ける：
$4.01
24時間の取引高:
680.87K
Relative Volume:
0.27
時価総額：
$346.64M
収益：
-
当期純損益:
$-36.95M
株価収益率:
-4.8214
EPS:
-0.84
ネットキャッシュフロー:
$-33.46M
1週間 パフォーマンス:
+9.46%
1か月 パフォーマンス:
+20.18%
6か月 パフォーマンス:
+39.18%
1年 パフォーマンス:
-33.72%
1日の値動き範囲:
$3.8901
$4.09
1週間の範囲:
$3.71
$4.0942
52週間の値動き範囲:
$1.61
$6.3065
Larimar Therapeutics Inc Stock (LRMR) Company Profile
名前
Larimar Therapeutics Inc
セクター
電話
844-511-9056
住所
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA
LRMR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LRMR
Larimar Therapeutics Inc
|
4.05 | 344.07M | 0 | -36.95M | -33.46M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Larimar Therapeutics Inc Stock (LRMR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-29 | 開始されました | Truist | Buy |
| 2024-10-16 | 開始されました | Oppenheimer | Outperform |
| 2024-10-03 | 開始されました | Wedbush | Outperform |
| 2024-10-02 | 開始されました | H.C. Wainwright | Buy |
| 2024-09-04 | 開始されました | Robert W. Baird | Outperform |
| 2024-04-03 | 開始されました | Leerink Partners | Outperform |
| 2023-11-17 | アップグレード | Citigroup | Neutral → Buy |
| 2022-10-19 | 開始されました | Guggenheim | Buy |
| 2022-02-15 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-02-10 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-02-01 | 開始されました | William Blair | Outperform |
すべてを表示
Larimar Therapeutics Inc (LRMR) 最新ニュース
Get in on Larimar Therapeutics Inc’s (LRMR) buy-in window today! - setenews.com
Can Larimar Therapeutics Inc. stock sustain market leadership2025 Winners & Losers & Weekly Return Optimization Alerts - Newser
How geopolitical risks impact Larimar Therapeutics Inc. (ZA71) stockMarket Rally & AI Enhanced Execution Alerts - Newser
Top 3 Health Care Stocks That May Rocket Higher In December - Benzinga
How Larimar Therapeutics Inc. (ZA71) stock behaves in tightening cyclesAnalyst Upgrade & Proven Capital Preservation Methods - Newser
Will Larimar Therapeutics Inc. (ZA71) stock recover faster than industry2025 Big Picture & Free AI Powered Buy and Sell Recommendations - Newser
Will Larimar Therapeutics Inc. (ZA71) stock profit from automation wave2025 Trade Ideas & Weekly Watchlist for Hot Stocks - Newser
Top investors say Larimar Therapeutics Inc (LRMR) ticks everything they need - Setenews
Why Larimar Therapeutics Inc. (ZA71) stock stays undervaluedWeekly Trend Recap & Comprehensive Market Scan Insights - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages Larimar Therapeutic - The National Law Review
Is Larimar Therapeutics Inc a good long term investmentStock Rotation Strategies & High Return Capital Strategies - earlytimes.in
Short Covering May Lift Piccadily Sugar Allied Industries Limited in Near TermPrice Channel Trading & Small Budget Trading Tips - earlytimes.in
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Will Larimar Therapeutics Inc. stock outperform value stocks2025 Market WrapUp & Weekly Top Gainers Trade List - moha.gov.vn
Published on: 2025-11-27 11:17:59 - moha.gov.vn
Published on: 2025-11-26 23:31:58 - moha.gov.vn
Are Smart Investors Making the Right Decision? Larimar Therapeutics Inc (LRMR) - setenews.com
Larimar Therapeutics Advances Phase 1 Study on Nomlabofusp for Friedreich’s Ataxia - MSN
Should You Track Oswal Yarns Limited as a LongTerm Growth PlayTechnical Analysis Insights & Learn to Trade with Real-Time Feedback - earlytimes.in
Is Larimar Therapeutics Inc. stock a smart buy before Fed meetingForecast Cut & Daily Profit Focused Screening - newser.com
Larimar Therapeutics Highlights Promising Friedreich’s Ataxia Data - MSN
Why Larimar Therapeutics Inc. (ZA71) stock stays on top picksMarket Growth Review & Risk Controlled Swing Alerts - newser.com
Why Larimar Therapeutics Inc. stock is favored by pension fundsProfit Target & Verified Stock Trade Ideas - newser.com
Detecting price anomalies in Larimar Therapeutics Inc. with AIMarket Trend Report & Capital Efficiency Focused Strategies - newser.com
Multi factor analysis applied to Larimar Therapeutics Inc.Quarterly Market Summary & Safe Capital Allocation Plans - newser.com
Published on: 2025-11-19 03:24:17 - newser.com
Published on: 2025-11-19 01:23:45 - newser.com
Larimar Therapeutics Inc. stock retracement – recovery analysisJuly 2025 Macro Moves & Capital Protection Trading Alerts - newser.com
What machine learning models say about Larimar Therapeutics Inc.2025 Sector Review & Accurate Entry/Exit Alerts - newser.com
How moving averages guide Larimar Therapeutics Inc. tradingStock Surge & Verified Short-Term Plans - newser.com
What institutional flow reveals about Larimar Therapeutics Inc.Portfolio Return Summary & Real-Time Buy Signal Notifications - newser.com
Larimar Therapeutics, Inc.Common Stock (NQ: LRMR - Markets Financial Content
Will Larimar Therapeutics Inc. stock outperform Dow Jones indexInsider Buying & Free Verified High Yield Trade Plans - newser.com
Will Larimar Therapeutics Inc. stock gain from lower inflationCEO Change & Consistent Growth Equity Picks - newser.com
How Larimar Therapeutics Inc. stock trades during market volatilityJuly 2025 Gainers & Consistent Income Trade Ideas - newser.com
Will Larimar Therapeutics Inc. stock benefit from automationJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - newser.com
Larimar Therapeutics Shows Promise in Friedreich’s Ataxia Treatment - MSN
Here's Why We're Watching Larimar Therapeutics' (NASDAQ:LRMR) Cash Burn Situation - Yahoo Finance
Larimar Therapeutics Inc (LRMR) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):